3a-diagnostics

3a-diagnostics is a research-based biotechnology company located in the southeast of Stuttgart, Germany, specializing in the development, production, and marketing of point-of-care testing systems. 3a has developed a series of peptide-based biosensor screening tests for bacterial and viral infectious diseases, including stomatitis, peri-implantitis, periodontitis, scarlet fever, and influenza. Positive detection of pathogenic pathogens leads to the enzymatic release of an extreme (but safe) bitter compound. 3a has also designed a scalable next-generation microbial enzyme screening tool for high-throughput identification of biosensor targets to facilitate the rapid development of new tests.